More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.

Systemic lupus erythematosus (SLE) significantly affects different aspects of patients' health-related quality of life (HRQOL). In 1998, Outcome Measures in Rheumatology (OMERACT) proposed the first Core Domain Set (CDS) for SLE, which included disease activity, organ damage, adverse events, HRQOL, and economic costs..